@BonesOfTheMoon to News • 5 months agoGilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial.www.cnbc.comexternal-linkmessage-square4arrow-up1174arrow-down12cross-posted to: [email protected][email protected]healthnews
arrow-up1172arrow-down1external-linkGilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial.www.cnbc.com@BonesOfTheMoon to News • 5 months agomessage-square4cross-posted to: [email protected][email protected]healthnews
minus-square555link9•5 months agoLenmeldy would like a word with you. $4.25m for a one-time treatment. But yes, $26k/y is outrageous.
Lenmeldy would like a word with you.
$4.25m for a one-time treatment.
But yes, $26k/y is outrageous.